Bank of England Drops Interest Rate 0.25%

NEWS
M&A advisorycorporate financeMorphose Capital Partners
By Morphose•10 February 2025
Bank of England Drops Interest Rate 0.25%

The Bank of England’s 0.25% interest rate cut to 4.5% last Thursday presents a valuable opportunity for SMEs. Lower borrowing costs mean cheaper debt finance and greater access to capital—both important for growth and strategic acquisitions.

For businesses with existing loans (subject to terms), reduced interest repayments will free up cash flow, creating room to reinvest, expand, or explore M&A opportunities. With debt financing now more affordable, businesses considering acquisitions may find this a good time to engage potential targets and start discussions - which can take time, going back and forth to reach heads or an alternative conclusion, by which time the base rate could well have lowered further.

At Morphose, we help founder-owned SMEs find the right exit partners, identify acquisition targets, and secure funding for growth strategies.
If you're considering an acquisition or exit, let’s meet up to talk.

While we're still a long way off the 0.25% base interest rate of 2020, and with inflation hovering around 2.5%—anticipated to rise to 3.7% by Q3 2025—it is still substantially below the 11.1% peak of October 2022. The big question is whether inflation can be stabilised. If it can, we will likely see further base rate cuts, that will help boost confidence and further stimulate M&A activity.

Morphose Capital Partners Team

About Morphose Capital Partners

Morphose Capital Partners is a leading advisory firm specializing in mergers & acquisitions, corporate finance, and strategic transactions for owner-managed businesses across the UK.

With decades of combined experience, our team provides expert guidance through every stage of your business journey – from early-stage funding and growth capital to strategic exits and business sales.

We pride ourselves on building long-term relationships with our clients, offering personalized service and deep sector expertise to help you achieve your business objectives while maximizing value at every opportunity.

Related Articles

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations
NEWS
12 February 2026By Sara Lavallin

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Read More
Can The Ghost of CGT Past Forecast What's to Come?
NEWS
3 November 2025By Elena Balsera

Can The Ghost of CGT Past Forecast What's to Come?

Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Read More
Introducing Dr Tom McColm
NEWS
3 November 2025By Elena Balsera

Introducing Dr Tom McColm

Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.

Read More